{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:50:08Z","timestamp":1777395008694,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:p>Background: Alzheimer\u2019s disease (AD) is conceptualized as a biological continuum encompassing the preclinical (clinically asymptomatic but with evidence of AD pathology) and clinical (symptomatic) phases. Objective: Using 18F-THK5351 as a tracer that binds to both tau and monoamine oxidase B (MAO-B), we investigated the changes in 18F-THK5351 accumulation patterns in AD continuum individuals with positive amyloid PET consisting of cognitively normal individuals (CNp), amnestic mild cognitive impairment (aMCI), and AD and cognitively normal individuals (CNn) with negative amyloid PET. Methods: We studied 69 individuals (32 CNn, 11 CNp, 9 aMCI, and 17 AD) with structural magnetic resonance imaging, 11C-Pittsburgh compound-B (PIB) and 18F-THK5351 PET, and neuropsychological assessment. 18F-THK5351 accumulation was evaluated with visual analysis, voxel-based analysis and combined region of interest (ROI)-based analysis corresponding to Braak neurofibrillary tangle stage. Results: On visual analysis, 18F-THK5351 accumulation was increased with stage progression in the AD continuum. On voxel-based analysis, there was no statistical difference in 18F-THK5351 accumulation between CNp and CNn. However, a slight increase of the bilateral posterior cingulate gyrus in aMCI and definite increase of the bilateral parietal temporal association area and posterior cingulate gyrus\/precuneus in AD were detected compared with CNn. On ROI-based analyses, 18F-THK5351 accumulation correlated positively with supratentorial 11C-PIB accumulation and negatively with the hippocampal volume and neuropsychological assessment. Conclusion: The AD continuum showed an increase in 18F-THK5351 with stage progression, suggesting that 18F-THK5351 has the potential to visualize the severity of tau deposition and neurodegeneration in accordance with the AD continuum.<\/jats:p>","DOI":"10.3233\/jad-215024","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T11:09:25Z","timestamp":1636715365000},"page":"223-234","source":"Crossref","is-referenced-by-count":7,"title":["Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer\u2019s Disease Continuum"],"prefix":"10.1177","volume":"85","author":[{"given":"Takashi","family":"Nihashi","sequence":"first","affiliation":[{"name":"Department of Radiology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"MULNIAD Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"},{"name":"Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ikenuma","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Arahata","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Washimi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Innovation Center for Translational Research, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Bundo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Aoba Ward, Sendai, Miyagi, Japan"},{"name":"Department of Pharmacology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yanai","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Aoba Ward, Sendai, Miyagi, Japan"},{"name":"Department of Pharmacology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Ito","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215024_ref1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215024_ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-215024_ref3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215024_ref4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215024_ref5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-215024_ref6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-215024_ref7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-215024_ref8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JAD-215024_ref9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"quantification of neurofibrillary tangles with [(18)F]MK-6240","volume":"10","author":"Pascoal","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-215024_ref10","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","article-title":"18F-MK-6240 PET for early and late detection of neurofibrillary tangles","volume":"143","author":"Pascoal","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-215024_ref11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","article-title":"Preclinical characterization of 18F-MK-6240, a promising PET tracer for quantification of human neurofibrillary tangles","volume":"57","author":"Hostetler","year":"2016","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer disease and healthy controls: A first-in-humans study","volume":"61","author":"Mueller","year":"2020","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","article-title":"High-contrast imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron"},{"key":"10.3233\/JAD-215024_ref14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","article-title":"Astrocyte biomarkers in Alzheimer\u2019s disease","volume":"25","author":"Carter","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.3233\/JAD-215024_ref15","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer\u2019s disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-215024_ref16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/cells10030540","article-title":"Astrocytes in Alzheimer\u2019s disease: Pathological significance and molecular pathways","volume":"10","author":"Preman","year":"2021","journal-title":"Cells"},{"key":"10.3233\/JAD-215024_ref17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2967\/jnumed.120.244400","article-title":"(18)F-SMBT-1: A selective and reversible PET tracer for monoamine oxidase-B imaging","volume":"62","author":"Harada","year":"2021","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref18","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-215024_ref20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of (18)F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease","volume":"59","author":"Harada","year":"2018","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2017.08.008","article-title":"Tau positron emission tomography using [(18)F]THK5351 and cerebral glucose hypometabolism in Alzheimer\u2019s disease","volume":"59","author":"Kang","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215024_ref22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fneur.2019.00503","article-title":"Tau PET with (18)F-THK-5351 Taiwan patients with familial Alzheimer\u2019s disease with the APP p.D678H mutation","volume":"10","author":"Huang","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-215024_ref23","doi-asserted-by":"crossref","first-page":"e0226265","DOI":"10.1371\/journal.pone.0226265","article-title":"Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer\u2019s disease differ according to disease severity and amyloid positivity","volume":"14","author":"Park","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215024_ref24","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1038\/s41598-017-06876-8","article-title":"Early functional network alterations inasymptomatic elders at risk for Alzheimer\u2019s disease","volume":"7","author":"Nakamura","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-215024_ref25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215024_ref26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215024_ref27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3233\/JAD-141338","article-title":"Prediction of outcomes in mild cognitive impairment by using 18F-FDG-PET: A multicenter study","volume":"45","author":"Ito","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215024_ref28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/brain\/awy044","article-title":"Electromagnetic signatures of the preclinical and prodromalstages of Alzheimer\u2019s disease","volume":"141","author":"Nakamura","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JAD-215024_ref29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-170257","article-title":"Decreased glucose metabolism in medial prefrontal areas is associated with nutritional status in patients with prodromal and early Alzheimer\u2019s disease","volume":"60","author":"Sugimoto","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215024_ref30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jlcr.854","article-title":"A rapid one-stepradiosynthesis of the beta-amyloid imaging radiotracer N-methyl-[C-11]2-(4\u2019-methylaminophenyl)-6-hydroxybenzothiazole ([C-11]-6-OH-BTA-1)","volume":"47","author":"Wilson","year":"2004","journal-title":"J Labelled Compds Radiopharm"},{"key":"10.3233\/JAD-215024_ref31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: A novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada","year":"2016","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-215024_ref32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data","volume":"92","author":"Greve","year":"2014","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-215024_ref33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","article-title":"Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging","volume":"132","author":"Greve","year":"2016","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-215024_ref34","doi-asserted-by":"crossref","first-page":"e0158460","DOI":"10.1371\/journal.pone.0158460","article-title":"Dynamic PET measures of tau accumulation in cognitively normal older adults and Alzheimer\u2019s disease patients measured using [18F] THK-5351","volume":"11","author":"Lockhart","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215024_ref35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","article-title":"A computational atlas of the hippocampal formation using, ultra-high resolution MRI: Application to adaptive segmentation of MRI","volume":"115","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-215024_ref36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: Current status and future directions","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin Transl Imaging"},{"key":"10.3233\/JAD-215024_ref37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012109"},{"key":"10.3233\/JAD-215024_ref38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11682-018-9847-7","article-title":"PET imaging of tau protein targets: A methodology perspective","volume":"13","author":"Lois","year":"2019","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JAD-215024_ref39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-215024_ref40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.semnuclmed.2020.12.005","article-title":"Advances in brain amyloid imaging","volume":"51","author":"Krishnadas","year":"2021","journal-title":"Semin Nucl Med"},{"key":"10.3233\/JAD-215024_ref41","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-020-05156-4","article-title":"Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"48","author":"Bischof","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-215024_ref42","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-215024_ref43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3390\/cells9091941","article-title":"In vivo TSPO signal and neuroinflammation in Alzheimer\u2019s disease","volume":"9","author":"Tournier","year":"2020","journal-title":"Cells"},{"key":"10.3233\/JAD-215024_ref44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-215024_ref45","doi-asserted-by":"crossref","first-page":"101446","DOI":"10.1016\/j.arr.2021.101446","article-title":"Diagnostic accuracy of blood biomarkers for Alzheimer\u2019s disease and amnestic mild cognitive impairment: A systematic review and meta-analysis","volume":"71","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-215024_ref46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","article-title":"Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"128","author":"Qu","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-215024_ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0815-4"},{"key":"10.3233\/JAD-215024_ref48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: A head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:44Z","timestamp":1777370684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215024"}},"subtitle":[],"editor":[{"given":"Junichi","family":"Iga","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":48,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-215024","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}